Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis

Yannick Degboé, Michael Schiff, Michael Weinblatt, Roy Fleischmann, Harris A. Ahmad, Arnaud Constantin

Open source

DOI
10.3390/jcm9062017
Published
2020-06-26
Container
Journal of Clinical Medicine
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm9062017,
  title = {Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis},
  author = {Yannick Degboé and Michael Schiff and Michael Weinblatt and Roy Fleischmann and Harris A. Ahmad and Arnaud Constantin},
  year = {2020},
  journal = {Journal of Clinical Medicine},
  doi = {10.3390/jcm9062017},
  url = {https://doi.org/10.3390/jcm9062017}
}

RIS

TY  - JOUR
TI  - Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis
AU  - Yannick Degboé
AU  - Michael Schiff
AU  - Michael Weinblatt
AU  - Roy Fleischmann
AU  - Harris A. Ahmad
AU  - Arnaud Constantin
PY  - 2020
JO  - Journal of Clinical Medicine
DO  - 10.3390/jcm9062017
UR  - https://doi.org/10.3390/jcm9062017
ER  - 

APA

Degboé, Y., Schiff, M., Weinblatt, M., Fleischmann, R., Ahmad, H. A., & Constantin, A. (2020). Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis. Journal of Clinical Medicine. https://doi.org/10.3390/jcm9062017

Source records